Codexis to Participate in Jefferies Global Healthcare Conference
Codexis (NASDAQ: CDXS), a prominent enzyme engineering company, announced its participation in the Jefferies Global Healthcare Conference on June 5-6, 2024, in New York. Management will engage in a fireside chat on June 5 at 11:30 am ET. A live webcast and an archived replay will be accessible via Codexis' Investor Relations webpage.
- Participation in a high-profile event like the Jefferies Global Healthcare Conference may enhance Codexis' visibility and investor interest.
- The announcement of the live webcast and archived replay increases accessibility for investors, potentially broadening the audience.
- The PR does not provide any new financial data or business developments, leaving potential investors without concrete updates on company performance.
- Absent detailed information on upcoming projects or partnerships, the PR may not significantly impact stock performance.
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Jefferies Global Healthcare Conference, being held June 5-6, 2024, in New York, New York.
Management will participate in a fireside chat on Wednesday, June 5, 2024, at 11:30 am ET. A live webcast of the event will be available here and in the Investor Relations section of the Company’s website, http://ir.codexis.com. A replay will be archived for 90 days following the event.
About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com
FAQ
When is Codexis participating in the Jefferies Global Healthcare Conference?
What time is the Codexis fireside chat at the Jefferies Global Healthcare Conference?
Where can I watch the Codexis fireside chat from the Jefferies Global Healthcare Conference?
What is the stock symbol for Codexis?
